MedPath

Carbetocin

Generic Name
Carbetocin
Brand Names
Duratocin
Drug Type
Small Molecule
Chemical Formula
C45H69N11O12S
CAS Number
37025-55-1
Unique Ingredient Identifier
88TWF8015Y
Background

Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.

Indication

Used to control postpartum hemorrhage and bleeding after giving birth.

Associated Conditions
Postpartum Haemorrhage (PPH), Uterine Atony

Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery

Completed
Conditions
Carbetocin
Uterotonics
Uterine Atony With Hemorrhage
Cesarean Section Complications
First Posted Date
2019-05-22
Last Posted Date
2019-05-29
Lead Sponsor
Maisonneuve-Rosemont Hospital
Target Recruit Count
612
Registration Number
NCT03959436
Locations
🇨🇦

Maisonneuve-Rosemont hospital, Montreal, Quebec, Canada

Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections

Conditions
Postpartum Hemorrhage
Interventions
First Posted Date
2019-05-07
Last Posted Date
2019-05-13
Lead Sponsor
Ufuk University
Target Recruit Count
100
Registration Number
NCT03939806
Locations
🇹🇷

Ufuk University Faculty of Medicine Hospital, Ankara, Balgat, Turkey

Carbetocin Myocardium Trial 2014 Part 2

Phase 4
Completed
Conditions
Pregnancy Complications
Interventions
First Posted Date
2019-04-02
Last Posted Date
2025-03-25
Lead Sponsor
Oslo University Hospital
Target Recruit Count
240
Registration Number
NCT03899961
Locations
🇳🇴

Akershus University Hospital, Lørenskog, Norway

🇳🇴

Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet, Oslo, Norway

Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage

Not Applicable
Completed
Conditions
Postpartum Hemorrhage
Interventions
First Posted Date
2019-03-12
Last Posted Date
2021-09-29
Lead Sponsor
Aswan University Hospital
Target Recruit Count
135
Registration Number
NCT03870503
Locations
🇪🇬

Aswan University Hospital, Aswan, Egypt

Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage

Not Applicable
Completed
Conditions
Post Partum Hemorrhage
Interventions
First Posted Date
2019-03-12
Last Posted Date
2021-09-29
Lead Sponsor
Aswan University Hospital
Target Recruit Count
135
Registration Number
NCT03870256
Locations
🇪🇬

AswanUH, Aswan, Egypt

Carbetocin Versus Oxytocin Infusion Plus Tranexamic Acid During Cesarean Section

First Posted Date
2018-12-17
Last Posted Date
2019-02-15
Lead Sponsor
Aswan University Hospital
Target Recruit Count
400
Registration Number
NCT03777878
Locations
🇪🇬

Aswan University, Aswan, Egypt

Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery

Phase 4
Completed
Conditions
Postpartum Hemorrhage (Primary)
Interventions
First Posted Date
2018-11-28
Last Posted Date
2018-11-28
Lead Sponsor
Al-Kindy College of Medicine
Target Recruit Count
300
Registration Number
NCT03755531
Locations
🇮🇶

Al Kindy College of Medicine/ University of Baghdad, Baghdad, Iraq

Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study

Phase 4
Completed
Conditions
Cardiac Arrythmias
Interventions
First Posted Date
2018-10-23
Last Posted Date
2021-05-14
Lead Sponsor
University of British Columbia
Target Recruit Count
50
Registration Number
NCT03716076
Locations
🇨🇦

BC Women's Hospital, Vancouver, British Columbia, Canada

Carbetocin Versus Buccal Misoprostol Plus IV Tranexamic Acid for Prevention of Postpartum Hemorrhage at Cesarean Section

Not Applicable
Completed
Conditions
Cesarean Section Complications
Interventions
First Posted Date
2018-10-18
Last Posted Date
2020-08-05
Lead Sponsor
Aswan University Hospital
Target Recruit Count
400
Registration Number
NCT03710317
Locations
🇪🇬

Aswan University, Aswan, Egypt

Carbetocin Versus Oral Tranexamic Acid Plus, Buccal Misoprostol on Blood Loss After Vaginal Delivery

Not Applicable
Completed
Conditions
Postpartum Hemorrhage
Interventions
Drug: Tranexamic acid plus misoprostol
First Posted Date
2018-10-17
Last Posted Date
2020-08-05
Lead Sponsor
Aswan University Hospital
Target Recruit Count
360
Registration Number
NCT03708497
Locations
🇪🇬

AswanUH, Aswan, Egypt

🇪🇬

Aswan University, Aswan, Egypt

© Copyright 2025. All Rights Reserved by MedPath